Curium to acquire Lantheus in deal valued at up to $8 billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Curium Announces Definitive Agreement to Merge with Lantheus
August 3, 2026 7:31 AM EDTStrategic transaction would bring Curium's theranostics portfolio and global manufacturing platform together with Lantheus complementary U.S. radiodiagnostics business Total transaction consideration to Lantheus shareholders of up to $114.50 per share in cash for an aggregate transaction value of up to $8.0 billion representing a premium of 38% to Lantheus unaffected 60-day volume-weighted average price and a premium of 29% to Lantheus unaffected 30-day volume-weighted average price Provides for near-term certain value for Lantheus shareholders of $102.50 per share in cash at closing and up to an... More
